Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding

Haemophilia

Volumn 14, Issue 2, 2008, Pages 390-391

  Economou, Marina ^a   Teli, A ^a   Tzantzaroudi, A ^a   Tsatra, I ^a   Zavitsanakis, A ^a   Athanassiou metaxa, M ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 ANTIBODY; D DIMER; FIBRINOGEN; HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB;

ABDOMINAL PAIN; ACUTE APPENDICITIS; ADOLESCENT; ANTIBODY TITER; ARTHROPATHY; BLOOD TRANSFUSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; ERYTHROCYTE STRUCTURE; FIBRINOGEN BLOOD LEVEL; HEMATURIA; HEMOGLOBIN DETERMINATION; HEMOPHILIA A; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; LEUKOCYTE COUNT; MALE; MONOTHERAPY; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE CARE; POSTOPERATIVE THROMBOSIS; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTHROMBIN TIME; RECTUM HEMORRHAGE; THROMBOCYTE COUNT; TREATMENT DURATION;

ADOLESCENT; APPENDECTOMY; AUTOANTIBODIES; BLOOD COAGULATION FACTORS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FACTOR VIIA; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 40349098211     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01635.x     Document Type: Letter

References (5)

1. Mehta R, Parameswaran R, Shapiro D. An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agents. Haemophilia 2006; 12 (Suppl. 6): 54-61.
2. Shapiro A. Inhibitor treatment: State of the art. Dis Mon 2003; 49: 22-38.
3. Key N, Christie B, Henderson N, Nelsestuen G. Possible synergy between recombinant factor VIIa and prothrombin complex concentrated in hemophilia therapy. Thromb Haemost 2002; 88: 60-5.
4. Schneiderman J, Nugent D, Young G. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors. Haemophilia 2004; 10: 347-51.
5. Rosenfeld S, Watkinson K, Thompson B, MacFarlane D, Lentz S. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient. Thromb Haemost 2002; 87: 925-6.